BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71 AND Treatment
46 results:

  • 1. Nationwide Laboratory Surveillance of Progressive Multifocal Leukoencephalopathy in Japan: Fiscal Years 2011-2020.
    Nakamichi K; Miura Y; Shimokawa T; Takahashi K; Suzuki T; Funata N; Harada M; Mori K; Sanjo N; Yukitake M; Takahashi K; Hamaguchi T; Izaki S; Oji S; Nakahara J; Ae R; Kosami K; Nukuzuma S; Nakamura Y; Nomura K; Kishida S; Mizusawa H; Yamada M; Takao M; Ebihara H; Saijo M
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112948
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. JC virus-induced progressive multifocal leukoencephalopathy in a presumably healthy patient.
    Wang X; Chen J; Gong J; Wu Y; Liu XH
    BMC Neurol; 2022 Dec; 22(1):462. PubMed ID: 36494784
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report.
    Lambert N; El Moussaoui M; Ritacco C; Moïse M; Paulus A; Delvenne P; Baron F; Sadzot B; Maquet P
    Front Immunol; 2022; 13():889148. PubMed ID: 35592313
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good's syndrome.
    Deng Q; Yan Z; Yang Y; Wang J; Han Y; Feng X; Wang M; Zhang L; Wang M
    J Neurovirol; 2022 Feb; 28(1):177-180. PubMed ID: 35040090
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pml Differentially Regulates Growth and Invasion in brain cancer.
    Tampakaki M; Oraiopoulou ME; Tzamali E; Tzedakis G; Makatounakis T; Zacharakis G; Papamatheakis J; Sakkalis V
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208139
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
    Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
    J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
    Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
    Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Neurological complications of JC virus infection: A review].
    Moulignier A; Lecler A
    Rev Med Interne; 2021 Mar; 42(3):177-185. PubMed ID: 33168355
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Autophagic degradation of pml promotes susceptibility to HSV-1 by stress-induced corticosterone.
    Li W; Luo Z; Yan CY; Wang XH; He ZJ; Ouyang SH; Yan C; Liu LF; Zhou QQ; Mu HL; Gong HB; Duan WJ; Liang L; Kurihara H; Feng D; Li YF; He RR
    Theranostics; 2020; 10(20):9032-9049. PubMed ID: 32802177
    [No Abstract]    [Full Text] [Related]  

  • 10. Protein sumoylation with SUMO1 promoted by Pin1 in glioma stem cells augments glioblastoma malignancy.
    Zhang A; Tao W; Zhai K; Fang X; Huang Z; Yu JS; Sloan AE; Rich JN; Zhou W; Bao S
    Neuro Oncol; 2020 Dec; 22(12):1809-1821. PubMed ID: 32592588
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
    Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
    BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis.
    Schweitzer F; Laurent S; Fink GR; Barnett MH; Reddel S; Hartung HP; Warnke C
    Curr Opin Neurol; 2019 Jun; 32(3):305-312. PubMed ID: 30985373
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pembrolizumab treatment for Progressive Multifocal Leukoencephalopathy.
    Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
    N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Idiopathic CD4-positive lymphocytopenia-associated progressive multifocal leukoencephalopathy confirmed by brain biopsy following negative results of repeated CSF-JC-virus tests: a case report].
    Kano Y; Inoue H; Sakurai K; Yoshida M; Miura Y; Nakamichi K; Saijo M; Yuasa H
    Rinsho Shinkeigaku; 2018 Dec; 58(12):750-755. PubMed ID: 30487366
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Penalized maximum likelihood simultaneous longitudinal PET image reconstruction with difference-image priors.
    Ellis S; Reader AJ
    Med Phys; 2018 Jul; 45(7):3001-3018. PubMed ID: 29697144
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy associated with thymoma with immunodeficiency: a case report and literature review.
    Ueno T; Sato N; Kon T; Haga R; Nunomura JI; Nakamichi K; Saijo M; Tomiyama M
    BMC Neurol; 2018 Apr; 18(1):37. PubMed ID: 29631544
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes.
    Kantorová E; Bittšanský M; Sivák Š; Baranovičová E; Hnilicová P; Nosáľ V; Čierny D; Zeleňák K; Brück W; Kurča E
    BMC Cancer; 2017 Jun; 17(1):424. PubMed ID: 28629398
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Induction of senescence in primary glioblastoma cells by serum and TGFβ.
    Kumar R; Gont A; Perkins TJ; Hanson JEL; Lorimer IAJ
    Sci Rep; 2017 May; 7(1):2156. PubMed ID: 28526854
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia.
    Lutz M; Schulze AB; Rebber E; Wiebe S; Zoubi T; Grauer OM; Keßler T; Kerkhoff A; Lenz G; Berdel WE
    Cancer Res Treat; 2017 Apr; 49(2):548-552. PubMed ID: 27456945
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Arsenic trioxide disrupts glioma stem cells via promoting pml degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.